DE1667896A1 - Androgen-Antagonisten - Google Patents

Androgen-Antagonisten

Info

Publication number
DE1667896A1
DE1667896A1 DE19681667896 DE1667896A DE1667896A1 DE 1667896 A1 DE1667896 A1 DE 1667896A1 DE 19681667896 DE19681667896 DE 19681667896 DE 1667896 A DE1667896 A DE 1667896A DE 1667896 A1 DE1667896 A1 DE 1667896A1
Authority
DE
Germany
Prior art keywords
daa
eteroid
daduroh
naoh
anepruoh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681667896
Other languages
German (de)
English (en)
Inventor
Patchett Arthur Allan
Arth Glen Edward
Sarett Lewis Hastings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1667896A1 publication Critical patent/DE1667896A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
DE19681667896 1967-03-06 1968-03-05 Androgen-Antagonisten Pending DE1667896A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62059467A 1967-03-06 1967-03-06

Publications (1)

Publication Number Publication Date
DE1667896A1 true DE1667896A1 (de) 1971-07-22

Family

ID=24486552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681667896 Pending DE1667896A1 (de) 1967-03-06 1968-03-05 Androgen-Antagonisten

Country Status (3)

Country Link
DE (1) DE1667896A1 (enExample)
FR (1) FR1580878A (enExample)
GB (1) GB1188414A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2418977A1 (fr) * 1978-03-02 1979-09-28 Labo Electronique Physique Onduleur universel

Also Published As

Publication number Publication date
FR1580878A (enExample) 1969-09-12
GB1188414A (en) 1970-04-15

Similar Documents

Publication Publication Date Title
DE1195748B (de) Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
DE1543273C3 (de) 7 alpha-Methyl-Delta hoch 5(16) -steroide der Oestranreihe und Verfahren zu deren Herstellung
DE1244777B (de) Verfahren zur Herstellung von 7alpha-Methyl-16alpha-hydroxy-oestron bzw. -3, 16-diacetat
DE2007417A1 (de) Ein neues Oestratriol und ein Verfahren zu dessen Herstellung
DE1120446B (de) Verfahren zur Herstellung von 6-Methyl-3-oxo-í¸-steroiden
DE3741801A1 (de) 17-methylen-estratriene
DE1667896A1 (de) Androgen-Antagonisten
DE1568307A1 (de) Verfahren zur Herstellung neuer 19-Norandrostatriene
DE2100319C3 (de) Neue Östranverbindungen, ihre Herstellung und sie enthaltende Arzneimittel
DE1175228B (de) Verfahren zur Herstellung von Guanylhydra-zonen der Androstan- bzw. Pregnanreihe
DE2030685C3 (de) 17-Ureido verbindungen der Androstanreihe als Inhibitoren der Biosynthese von Androgenen und Verfahren zu deren Herstellung
DE1768700B1 (de) Ungesaettigte 2,2-Dimethyl-steroide der OEstran- bzw.Gonanreihe und Verfahren zu ihrer Herstellung
DE1793738C3 (de) 3-0A-11 beta-OB-17alpha-R-17beta-OH-östra-1,3,5 (10)-trlene und diese enthaltende Arzneimittel
DE1793608B1 (de) 17alpha-Alkyl-,-Alkenyl- oder -Alkinyl-13ss-alkylgon-4-oder-5(10)-en-17ss-ol-3-one
DE1668685C3 (de) 17-Hydroxy- und 17-Acyloxy-6 beta, 7 beta-epoxy-1 alpha, 2 alpha-methylen-4-pregnen-3,20-dione, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
AT233182B (de) Verfahren zur Herstellung von 6-Methyl-3-oxo-Δ<4,6>-steroiden
DE2218000C3 (de) Neue 17 beta-Tetrahydropyran-4yloxyäther von Steroiden
DE2118995A1 (de) Neue oestrogen hochwirksame Steroide und ein Verfahren zu deren Herstellung
DE1593465C (de) 3-(2Chloräthoxy> 17alpha-äthinyl-17 beta-hydroxy-Delta hoch 1,3,5(10)-östratrien und Verfahren zu dessen Herstellung
AT274258B (de) Verfahren zur Herstellung von neuen 7α-Methyl-Δ<4,9,11>-19-nor-androstatrienen
DE1926043C3 (de) Neue Östrogenäther und Verfahren zu ihrer Herstellung
DE1813083B2 (de) 11 beta-Methyl-19-norpregn-4-en 3,20-dione, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
DE1235315B (de) Verfahren zur Herstellung von 3, 11beta, 17beta-Trihydroxy-17alpha-aethinyl-delta 1,3,5(10)-oestratrien bzw. von 3-Estern oder 3-AEthern desselben
DE1814304C3 (de) 3-Oxo-12-methyl-östra-4,9*ll-triene, Verfahren zu ihrer Herstellung, diese enthaltende therapeutische Zusammensetzungen sowie die entsprechenden Zwischenprodukte
DE917971C (de) Verfahren zur Herstellung von Steroidlactamen